Comparative Pharmacology
Head-to-head clinical analysis: DEXTROSE 5 IN PLASTIC CONTAINER versus NORMOSOL R IN PLASTIC CONTAINER.
Peer-Reviewed Evidence
Head-to-head clinical analysis: DEXTROSE 5 IN PLASTIC CONTAINER versus NORMOSOL R IN PLASTIC CONTAINER.
DEXTROSE 5% IN PLASTIC CONTAINER vs NORMOSOL-R IN PLASTIC CONTAINER
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Dextrose is a monosaccharide that provides a source of calories and fluid for parenteral nutrition. It increases blood glucose levels and is metabolized to carbon dioxide and water, providing energy. It also serves as a source of water for hydration.
Normosol-R is an isotonic crystalloid solution that replaces extracellular fluid volume and electrolytes. It provides sodium, chloride, potassium, magnesium, acetate, and gluconate to maintain acid-base balance and osmotic equilibrium. Acetate and gluconate are metabolized to bicarbonate, providing an alkalinizing effect.
Intravenous infusion: 500-1000 mL as needed based on fluid and caloric requirements. Typical rate: 100-200 mL/hour for maintenance. Maximum infusion rate: 0.5-0.8 g/kg/hour.
Intravenous infusion; dose determined by electrolyte and fluid requirements; typical adult dose: 250-1000 mL/hour, not to exceed 30 mL/kg/day.
None Documented
None Documented
Intravenous: 1.5-2.5 hours for glucose clearance; prolonged in renal impairment or diabetes mellitus
Not applicable as a drug; the half-life of infused crystalloid components is distribution-dependent. Sodium and chloride have a terminal half-life of approximately 2-4 hours in healthy adults, reflecting renal clearance. Clinical context: Half-life prolonged in renal impairment.
Renal: negligible as unchanged drug; metabolized to water and carbon dioxide, excreted via lungs (>90%) and urine (glucose normally <0.1%)
Renal excretion of electrolytes and water; no hepatic metabolism. >95% of administered water and electrolytes are excreted renally, with small amounts lost via feces (<2%) and insensible losses.
Category C
Category C
Intravenous Fluid
Intravenous Fluid/Electrolyte Solution